Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Erionite exposure in North Dakota and Turkish villages with mesothelioma.

Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, Yang H, Miller A.

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13618-23. doi: 10.1073/pnas.1105887108. Epub 2011 Jul 25.

2.

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, Sander C, Delsite R, Powell S, Zhou Q, Shen R, Olshen A, Rusch V, Ladanyi M.

Nat Genet. 2011 Jun 5;43(7):668-72. doi: 10.1038/ng.855.

3.

Malignant mesothelioma: facts, myths, and hypotheses.

Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI, Yang H.

J Cell Physiol. 2012 Jan;227(1):44-58. doi: 10.1002/jcp.22724. Review.

4.

Frequent mutation of BAP1 in metastasizing uveal melanomas.

Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM.

Science. 2010 Dec 3;330(6009):1410-3. doi: 10.1126/science.1194472. Epub 2010 Nov 4.

5.

Health experts concerned over India's asbestos industry.

Burki T.

Lancet. 2010 Feb 20;375(9715):626-7. No abstract available.

PMID:
20198723
6.

Asbestos-induced lung diseases: an update.

Kamp DW.

Transl Res. 2009 Apr;153(4):143-52. doi: 10.1016/j.trsl.2009.01.004. Epub 2009 Feb 11. Review.

7.

Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005.

Moolgavkar SH, Meza R, Turim J.

Cancer Causes Control. 2009 Aug;20(6):935-44. doi: 10.1007/s10552-009-9328-9. Epub 2009 Mar 18.

PMID:
19294523
8.

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.

Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, Wilkinson KD.

Cancer Res. 2008 Sep 1;68(17):6953-62. doi: 10.1158/0008-5472.CAN-08-0365.

9.

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):620-6, 626.e1-3. doi: 10.1016/j.jtcvs.2007.10.054. Epub 2008 Feb 14.

10.

A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes.

Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, Baris YI.

Nat Rev Cancer. 2007 Feb;7(2):147-54. Review.

PMID:
17251920
11.

The French National Mesothelioma Surveillance Program.

Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux P, Boutin C, Launoy G, Pairon JC, Astoul P, Galateau-Sallé F, Brochard P.

Occup Environ Med. 2006 Jun;63(6):390-5. Epub 2006 Feb 9.

12.

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

13.

Residential proximity to naturally occurring asbestos and mesothelioma risk in California.

Pan XL, Day HW, Wang W, Beckett LA, Schenker MB.

Am J Respir Crit Care Med. 2005 Oct 15;172(8):1019-25. Epub 2005 Jun 23.

14.

Asbestos and its lethal legacy.

Tweedale G.

Nat Rev Cancer. 2002 Apr;2(4):311-5. Review.

PMID:
12001992
15.

The epidemiology of mesothelioma.

Britton M.

Semin Oncol. 2002 Feb;29(1):18-25. Review.

PMID:
11836665
16.

Genetic predisposition to ocular melanoma.

Houlston RS, Damato BE.

Eye (Lond). 1999;13 ( Pt 1):43-6. Review.

PMID:
10396383
17.

Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.

Murthy SS, Testa JR.

J Cell Physiol. 1999 Aug;180(2):150-7. Review.

PMID:
10395284
18.

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ 3rd.

Oncogene. 1998 Mar 5;16(9):1097-112.

PMID:
9528852
19.

Diverse mutations in patients with Menkes disease often lead to exon skipping.

Das S, Levinson B, Whitney S, Vulpe C, Packman S, Gitschier J.

Am J Hum Genet. 1994 Nov;55(5):883-9.

20.

Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma.

Lu YY, Jhanwar SC, Cheng JQ, Testa JR.

Genes Chromosomes Cancer. 1994 Jan;9(1):76-80.

PMID:
7507705

Supplemental Content

Support Center